INS and type 1 diabetes mellitus: In T1D patients, dasiglucagon restored euglycemia after insulin-induced hypoglycemia at doses from 0.1 to 1.0 mg [76], and provided rapid and effective reversal of hypoglycemia in adults with T1D, with safety and tolerability similar to those reported for reconstituted glucagon injection [77,78,79].